🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

We will be in Las Vegas tomorrow for the Society of Hospital Medicine's annual conference. During this event, we will discuss several important topics with our esteemed colleagues, including distributive shock, the latest developments in antimicrobial treatments, and ways to

Will we see you in Montreal for the Society of Cardiovascular Anesthesiologists' 47th Annual Meeting? We look forward to discussing key issues involved in delivering care to patients undergoing cardiovascular and thoracic surgeries. #SocietyofCardiovascularAnesthesiologists

This week, we recognize nurses as a fundamental part of the healthcare ecosystem. We work with hospitals and medical professionals to bring differentiated therapies to patients, and we value our work with all our healthcare partners. Happy National Nurses Week!

Did you know that May is Critical Care Awareness Month? We are proud to join in celebrating the dedicated individuals who work tirelessly to provide lifesaving care to critically ill patients worldwide. In the United States, more than 5.7 million patients are admitted annually to

Did you know that May is Older Americans Month? As we recognize the health and well-being of our elderly population, it is important to acknowledge that a high percentage of the deaths caused by the most common antibiotic-resistant infections occur in Americans 65 years and

The Centers for Disease Control and Prevention recently did a new analysis of US antimicrobial resistance (AMR) data from 2012 through 2022 and found that the burden of drug-resistant infection in hospitals fell but remains substantial. One of those pathogens of interest was

The National Teaching Institute and Critical Care Expo (NTI) kicks off today, and we’ll be in the Big Easy to join thousands of nurses and other healthcare professionals who are instrumental in helping prevent the spread of serious infections among some of the most vulnerable and

Today’s news underscores our commitment to investing in therapies that offer physicians new options for treating some of the most challenging and potentially deadly infections in patients. To learn more, and for full prescribing information, go here: urldefense.proofpoint.com/v2/url?u=https…

We are thrilled to announce the commercial launch of our latest antibiotic, an advanced-generation cephalosporin FDA-approved to treat three types of serious bacterial infections. We’re honored to partner with @Basilea Pharmaceutica, Ltd., to bring this new therapeutic option to

Join us at MAD-ID as we chat about how we can keep making a positive impact in the fight against infectious diseases! We’ll dive into conversations about antimicrobial stewardship and how to make the most of antimicrobial medications for better patient outcomes. We’d love for you

Check out the review article in the From the Bench to the Bedside series in the April issue of Anesthesiology News. Read the article: lnkd.in/euTiKDDm For prescribing and safety information, go to: giapreza.com.

The U.S. FDA acceptance of the new drug application for the investigational agent zoliflodacin represents a significant advancement in providing an innovative oral treatment option for the more than 82 million new gonorrhea infections that occur worldwide each year.

The American Society of Microbiology Conference begins tomorrow in Los Angeles. As a company dedicated to developing antibiotic therapies for serious, life-threatening infections, we are looking forward to attending the event.

We look forward to discussing therapeutic advances and innovative management strategies for perioperative vasoplegia at the upcoming Western Thoracic Surgical Association Meeting. We hope to see you there. #thoracic #surgeons #therapeuticadvances

For complete safety information and prescribing details, please visit zevtera.com

Our field force gathered this week for our official ZEVTERA®(ceftobiprole) launch meeting, preparing to introduce and support the rollout of our newest antibiotic. For safety and full prescribing information, visit zevtera.com

Did you know that research shows a significant number of new Sexually Transmitted Infections (STIs) occur among college students, and that freshmen and sophomores are more likely to be infected than juniors and seniors? Learn more here: cdc.gov/gonorrhea/abou…

As a company focused on developing therapies to combat difficult to treat infectious diseases, we support antibiotic stewardship efforts and the healthcare professionals who are protecting our communities from emerging infectious threats.

Did you know that undiagnosed STDs cost the U.S. about $16 billion each year in direct medical expenses? Considering that nearly 1 in 5 people in the U.S. have an STD at any given time, it's clear that we need to continue having discussions about prevention and treatment.

Transplant patients deserve protection that matches the complexity of their care, and we’re committed to advancing therapies that address serious infections and unmet needs in immunocompromised populations, including organ transplant recipients. Will we see you at WTC2025?